{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:47:15Z","timestamp":1791416835502,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T00:00:00Z","timestamp":1489708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T00:00:00Z","timestamp":1489708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Melanoma of the uveal tract accounts for approximately 5% of all melanomas and represents the most common primary intraocular malignancy. Despite improvements in diagnosis and more effective local therapies for primary cancer, the rate of metastatic death has not changed in the past forty years. In the present study, we made use of bioinformatics to analyze the data obtained from three public available microarray datasets on uveal melanoma in an attempt to identify novel putative chemotherapeutic options for the liver metastatic disease. We have first carried out a meta-analysis of publicly available whole-genome datasets, that included data from 132 patients, comparing metastatic vs. non metastatic uveal melanomas, in order to identify the most relevant genes characterizing the spreading of tumor to the liver. Subsequently, the L1000CDS<jats:sup>2<\/jats:sup> web-based utility was used to predict small molecules and drugs targeting the metastatic uveal melanoma gene signature. The most promising drugs were found to be Cinnarizine, an anti-histaminic drug used for motion sickness, Digitoxigenin, a precursor of cardiac glycosides, and Clofazimine, a fat-soluble iminophenazine used in leprosy. <jats:italic>In vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> validation studies will be needed to confirm the efficacy of these molecules for the prevention and treatment of metastatic uveal melanoma.<\/jats:p>","DOI":"10.1038\/srep44564","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T10:58:40Z","timestamp":1489748320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Identification of novel chemotherapeutic strategies for metastatic uveal melanoma"],"prefix":"10.1038","volume":"7","author":[{"given":"Paolo","family":"Fagone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Caltabiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelina Daniela","family":"Anfuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sofia","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"De Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Libra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Reibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,17]]},"reference":[{"key":"BFsrep44564_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2350-15-29","volume":"15","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y., Yang, Y., Chen, L. & Zhang, J. Expression analysis of genes and pathways associated with liver metastases of the uveal melanoma. BMC Med. Genet. 15, 29 (2014).","journal-title":"BMC Med. Genet."},{"key":"BFsrep44564_CR2","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/cncr.20866","volume":"103","author":"CC McLaughlin","year":"2005","unstructured":"McLaughlin, C. C. et al. Incidence of noncutaneous melanomas in the U.S. Cancer 103, 1000\u20137 (2005).","journal-title":"Cancer"},{"key":"BFsrep44564_CR3","first-page":"763","volume":"23","author":"JA Shields","year":"1996","unstructured":"Shields, J. A., Shields, C. L., De Potter, P. & Singh, A. D. Diagnosis and treatment of uveal melanoma. Semin. Oncol. 23, 763\u20137 (1996).","journal-title":"Semin. Oncol."},{"key":"BFsrep44564_CR4","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/cncr.29727","volume":"122","author":"C Chattopadhyay","year":"2016","unstructured":"Chattopadhyay, C. et al. Uveal melanoma: From diagnosis to treatment and the science in between. Cancer 122, 2299\u20132312 (2016).","journal-title":"Cancer"},{"key":"BFsrep44564_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archopht.119.7.969","volume":"119","author":"M Diener-West","year":"2001","unstructured":"Diener-West, M. et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch. Ophthalmol. (Chicago, Ill. 1960) 119, 969\u201382 (2001).","journal-title":"Arch. Ophthalmol. (Chicago, Ill. 1960)"},{"key":"BFsrep44564_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0360-3016(02)04200-1","volume":"55","author":"E Egger","year":"2003","unstructured":"Egger, E. et al. Eye retention after proton beam radiotherapy for uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys. 55, 867\u201380 (2003).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFsrep44564_CR7","doi-asserted-by":"crossref","unstructured":"Clough, E. & Barrett, T. In 93\u2013110, doi: 10.1007\/978-1-4939-3578-9_5 (2016).","DOI":"10.1007\/978-1-4939-3578-9_5"},{"key":"BFsrep44564_CR8","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1158\/0008-5472.CAN-10-0605","volume":"71","author":"C Laurent","year":"2011","unstructured":"Laurent, C. et al. High PTP4A3 Phosphatase Expression Correlates with Metastatic Risk in Uveal Melanoma Patients. Cancer Res. 71, 666\u2013674 (2011).","journal-title":"Cancer Res."},{"key":"BFsrep44564_CR9","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-15-2071","volume":"22","author":"MG Field","year":"2016","unstructured":"Field, M. G. et al. PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma. Clin. Cancer Res. 22, 1234\u20131242 (2016).","journal-title":"Clin. Cancer Res."},{"key":"BFsrep44564_CR10","doi-asserted-by":"publisher","first-page":"W63","DOI":"10.1093\/nar\/gkt338","volume":"41","author":"J Xia","year":"2013","unstructured":"Xia, J. et al. INMEX\u2013a web-based tool for integrative meta-analysis of expression data. Nucleic Acids Res. 41, W63\u201370 (2013).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep44564_CR11","doi-asserted-by":"publisher","first-page":"W115","DOI":"10.1093\/nar\/gkt533","volume":"41","author":"K Zuberi","year":"2013","unstructured":"Zuberi, K. et al. GeneMANIA Prediction Server 2013 Update. Nucleic Acids Res. 41, W115\u2013W122 (2013).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep44564_CR12","doi-asserted-by":"publisher","first-page":"D336","DOI":"10.1093\/nar\/gkv1194","volume":"44","author":"H Mi","year":"2016","unstructured":"Mi, H., Poudel, S., Muruganujan, A., Casagrande, J. T. & Thomas, P. D. PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res. 44, D336\u2013D342 (2016).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep44564_CR13","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gku476","volume":"42","author":"Q Duan","year":"2014","unstructured":"Duan, Q. et al. LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures. Nucleic Acids Res. 42, W449\u201360 (2014).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep44564_CR14","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.3747\/co.23.2859","volume":"23","author":"E Weis","year":"2016","unstructured":"Weis, E. et al. Management of uveal melanoma: a consensus-based provincial clinical practice guideline. Curr. Oncol. 23, e57\u201364 (2016).","journal-title":"Curr. Oncol"},{"key":"BFsrep44564_CR15","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh, A. D., Turell, M. E. & Topham, A. K. Uveal Melanoma: Trends in Incidence, Treatment, and Survival. Ophthalmology 118, 1881\u20131885 (2011).","journal-title":"Ophthalmology"},{"key":"BFsrep44564_CR16","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1158\/1078-0432.CCR-06-0818","volume":"12","author":"B Peruzzi","year":"2006","unstructured":"Peruzzi, B. & Bottaro, D. P. Targeting the c-Met signaling pathway in cancer. Clin. Cancer Res. 12, 3657\u201360 (2006).","journal-title":"Clin. Cancer Res."},{"key":"BFsrep44564_CR17","first-page":"2","volume":"6","author":"S Di Cesare","year":"2007","unstructured":"Di Cesare, S. et al. Expression and migratory analysis of 5 human uveal melanoma cell lines for CXCL12, CXCL8, CXCL1, and HGF. J. Carcinog. 6, 2 (2007).","journal-title":"J. Carcinog"},{"key":"BFsrep44564_CR18","first-page":"1","volume":"43","author":"C All-Ericsson","year":"2002","unstructured":"All-Ericsson, C. et al. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. Invest. Ophthalmol. Vis. Sci. 43, 1\u20138 (2002).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFsrep44564_CR19","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00262-007-0303-6","volume":"56","author":"S Scala","year":"2007","unstructured":"Scala, S. et al. CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type. Cancer Immunol. Immunother. 56, 1589\u20131595 (2007).","journal-title":"Cancer Immunol. Immunother."},{"key":"BFsrep44564_CR20","first-page":"13","volume":"2","author":"R Franco","year":"2010","unstructured":"Franco, R. et al. &quot;CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression&quot;. Front . Biosci. (Elite Ed). 2, 13\u201321 (2010).","journal-title":"Biosci. (Elite Ed)."},{"key":"BFsrep44564_CR21","doi-asserted-by":"publisher","first-page":"e29989","DOI":"10.1371\/journal.pone.0029989","volume":"7","author":"R Gangemi","year":"2012","unstructured":"Gangemi, R. et al. Mda-9\/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression. PLoS One 7, e29989 (2012).","journal-title":"PLoS One"},{"key":"BFsrep44564_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/cam4.133","volume":"2","author":"K Buder","year":"2013","unstructured":"Buder, K., Gesierich, A., Gelbrich, G. & Goebeler, M. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives. Cancer Med. 2, 674\u201386 (2013).","journal-title":"Cancer Med"},{"key":"BFsrep44564_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/978-1-62703-727-3_22","volume":"1102","author":"JW Harbour","year":"2014","unstructured":"Harbour, J. W. A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile. Methods Mol. Biol. 1102, 427\u201340 (2014).","journal-title":"Methods Mol. Biol"},{"key":"BFsrep44564_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00508-015-0905-5","volume":"128","author":"A-W Scholtz","year":"2016","unstructured":"Scholtz, A.-W., Ilgner, J., Loader, B., Pritschow, B. W. & Weisshaar, G. Cinnarizine and dimenhydrinate in the treatment of vertigo in medical practice. Wien. Klin. Wochenschr. 128, 341\u2013347 (2016).","journal-title":"Wien. Klin. Wochenschr."},{"key":"BFsrep44564_CR25","doi-asserted-by":"crossref","unstructured":"Cholo, M. C., Mothiba, M. T., Fourie, B. & Anderson, R. Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline. J. Antimicrob. Chemother. dkw426, doi: 10.1093\/jac\/dkw426 (2016).","DOI":"10.1093\/jac\/dkw426"},{"key":"BFsrep44564_CR26","first-page":"484","volume":"36","author":"SJ Aguilar","year":"1975","unstructured":"Aguilar, S. J. An open study of mesoridazine (Serentil) in chronic schizophrenics. Dis. Nerv. Syst. 36, 484\u20139 (1975).","journal-title":"Dis. Nerv. Syst"},{"key":"BFsrep44564_CR27","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","volume":"2","author":"GB Rogers","year":"2014","unstructured":"Rogers, G. B., Bruce, K. D., Martin, M. L., Burr, L. D. & Serisier, D. J. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. Lancet Respir. Med. 2, 988\u2013996 (2014).","journal-title":"Lancet Respir. Med."},{"key":"BFsrep44564_CR28","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1021\/ja102758v","volume":"132","author":"KV Butler","year":"2010","unstructured":"Butler, K. V. et al. Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A. J. Am. Chem. Soc. 132, 10842\u201310846 (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"BFsrep44564_CR29","doi-asserted-by":"publisher","first-page":"22622","DOI":"10.1038\/srep22622","volume":"6","author":"W Dai","year":"2016","unstructured":"Dai, W., Zhou, J., Jin, B. & Pan, J. Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma. Sci. Rep. 6, 22622 (2016).","journal-title":"Sci. Rep"},{"key":"BFsrep44564_CR30","doi-asserted-by":"publisher","first-page":"6612","DOI":"10.1167\/iovs.14-15202","volume":"55","author":"W Van der Ent","year":"2014","unstructured":"Van der Ent, W. et al. Modeling of Human Uveal Melanoma in Zebrafish Xenograft Embryos. Investig. Opthalmology Vis. Sci. 55, 6612 (2014).","journal-title":"Investig. Opthalmology Vis. Sci"},{"key":"BFsrep44564_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.intimp.2014.05.024","volume":"21","author":"I Venza","year":"2014","unstructured":"Venza, I., Visalli, M., Oteri, R., Teti, D. & Venza, M. Class I-specific histone deacetylase inhibitor MS-275 overrides TRAIL-resistance in melanoma cells by downregulating c-FLIP. Int. Immunopharmacol. 21, 439\u2013446 (2014).","journal-title":"Int. Immunopharmacol."},{"key":"BFsrep44564_CR32","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1167\/iovs.12-10977","volume":"54","author":"X Chen","year":"2013","unstructured":"Chen, X. et al. MicroRNA-124a Is Epigenetically Regulated and Acts as a Tumor Suppressor by Controlling Multiple Targets in Uveal Melanoma. Investig. Opthalmology Vis. Sci. 54, 2248 (2013).","journal-title":"Investig. Opthalmology Vis. Sci"},{"key":"BFsrep44564_CR33","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","volume":"18","author":"S Landreville","year":"2012","unstructured":"Landreville, S. et al. Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma. Clin. Cancer Res. 18, 408\u2013416 (2012).","journal-title":"Clin. Cancer Res."},{"key":"BFsrep44564_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00008390-200506000-00002","volume":"15","author":"DD Klisovic","year":"2005","unstructured":"Klisovic, D. D. et al. Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma. Melanoma Res. 15, 147\u201353 (2005).","journal-title":"Melanoma Res."},{"key":"BFsrep44564_CR35","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1167\/iovs.02-1052","volume":"44","author":"DD Klisovic","year":"2003","unstructured":"Klisovic, D. D. et al. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. Invest. Ophthalmol. Vis. Sci. 44, 2390\u20138 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFsrep44564_CR36","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1167\/iovs.10-5272","volume":"52","author":"X Chen","year":"2011","unstructured":"Chen, X. et al. Epigenetics, MicroRNAs, and Carcinogenesis: Functional Role of MicroRNA-137 in Uveal Melanoma. Investig. Opthalmology Vis. Sci. 52, 1193 (2011).","journal-title":"Investig. Opthalmology Vis. Sci"},{"key":"BFsrep44564_CR37","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1167\/iovs.09-5004","volume":"51","author":"J Dopierala","year":"2010","unstructured":"Dopierala, J., Damato, B. E., Lake, S. L., Taktak, A. F. G. & Coupland, S. E. Genetic Heterogeneity in Uveal Melanoma Assessed by Multiplex Ligation-Dependent Probe Amplification. Investig. Opthalmology Vis. Sci. 51, 4898 (2010).","journal-title":"Investig. Opthalmology Vis. Sci"},{"key":"BFsrep44564_CR38","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/bjc.2015.269","volume":"113","author":"A-A Nabil","year":"2015","unstructured":"Nabil, A.-A. et al. Upcoming translational challenges for uveal melanoma. Br. J. Cancer 113, 1249\u20131253 (2015).","journal-title":"Br. J. Cancer"},{"key":"BFsrep44564_CR39","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.1038\/onc.2013.555","volume":"33","author":"MS Sagoo","year":"2014","unstructured":"Sagoo, M. S., Harbour, J. W., Stebbing, J. & Bowcock, A. M. Combined PKC and MEK inhibition for treating metastatic uveal melanoma. Oncogene 33, 4722\u20134723 (2014).","journal-title":"Oncogene"},{"key":"BFsrep44564_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/159421","volume":"2011","author":"S Gaudi","year":"2011","unstructured":"Gaudi, S. & Messina, J. L. Molecular Bases of Cutaneous and Uveal Melanomas. Patholog. Res. Int. 2011, 1\u20138 (2011).","journal-title":"Patholog. Res. Int"},{"key":"BFsrep44564_CR41","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/448645a","volume":"448","author":"CR Chong","year":"2007","unstructured":"Chong, C. R. & Sullivan, D. J. New uses for old drugs. Nature 448, 645\u2013646 (2007).","journal-title":"Nature"},{"key":"BFsrep44564_CR42","first-page":"835","volume":"35","author":"LC Schmeel","year":"2015","unstructured":"Schmeel, L. C. et al. In vitro efficacy of cinnarizine against lymphoma and multiple myeloma. Anticancer Res. 35, 835\u201341 (2015).","journal-title":"Anticancer Res."},{"key":"BFsrep44564_CR43","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3390\/ijms12128787","volume":"12","author":"T-S Chang","year":"2011","unstructured":"Chang, T.-S. & Lin, V. C.-H. Melanogenesis Inhibitory Activity of Two Generic Drugs: Cinnarizine and Trazodone in Mouse B16 Melanoma Cells. Int. J. Mol. Sci. 12, 8787\u20138796 (2011).","journal-title":"Int. J. Mol. Sci."},{"key":"BFsrep44564_CR44","doi-asserted-by":"crossref","unstructured":"Zaccagnino, A. et al. Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma. Oncotarget, doi: 10.18632\/oncotarget.11299 (2014).","DOI":"10.18632\/oncotarget.11299"},{"key":"BFsrep44564_CR45","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bcp.2013.12.007","volume":"87","author":"AV Koval","year":"2014","unstructured":"Koval, A. V. et al. Anti-leprosy drug clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling. Biochem. Pharmacol. 87, 571\u2013578 (2014).","journal-title":"Biochem. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep44564.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep44564","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep44564.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:07:09Z","timestamp":1671840429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep44564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,17]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,4,20]]}},"alternative-id":["BFsrep44564"],"URL":"https:\/\/doi.org\/10.1038\/srep44564","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,17]]},"assertion":[{"value":"17 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44564"}}